A Phase IIa Study of Vitamin D3 Tolerogenic Dendritic Cells (tolDC) for Multiple Sclerosis
Clinical trial NCT07020715 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07020715
- Sponsor
- University Hospital, Antwerp
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-07-01
- Primary completion
- 2029-09-30
- Enrollment
- 14
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.